Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Belimumab may cause hair loss in lupus patients.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Targeting CXCL10 may help treat alopecia areata.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Accurate diagnosis and zinc supplements can improve life quality in acrodermatitis enteropathica, even with normal zinc levels.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Platelet-rich plasma is a safe and effective treatment for hair loss, with fewer relapses than steroid treatment.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Neonatal lupus symptoms usually resolve, but some children may develop other autoimmune diseases later.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

Scientists made antibodies to tell cashmere and wool apart, which could improve how we identify animal fibers.

People with alopecia areata often have thyroid autoimmunity.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

IL-13 protein is much higher in the skin of atopic dermatitis patients than in healthy skin.